Myriad Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Myriad Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-19,076	Closed	-$61K	–	64
2020 Q1	$61K	Hold	19,076	–	–	0.01%	93
2019 Q4	$91K	Hold	19,076	–	–	0.01%	91
2019 Q3	$125K	Buy	+19,076	New	+$106K	0.01%	91
2018 Q3	–	Sell	-367,540	Closed	-$3.69M	–	80
2018 Q2	$3.69M	Sell	367,540 -137,170	-27%	-$1.37M	0.51%	44
2018 Q1	$5.04M	Hold	504,710	–	–	0.45%	41
2017 Q4	$5.01M	Hold	504,710	–	–	0.49%	32
2017 Q3	$5.05M	Buy	+504,710	New	+$5.01M	0.49%	33

Other funds holding ORGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Myriad Asset Management's ORGO Position: Q2 2020 in Review

Myriad Asset Management sold out of Organogenesis Holdings (ORGO) in Q2 2020, closing a stake of 19,076 shares — an estimated $61K sold.

Myriad Asset Management first reported a position in ORGO in Q3 2017 and held it in 7 quarters. The position peaked at $5.05M in Q3 2017. 50 funds tracked by Wall St. Rank hold ORGO as of Q2 2020.

Myriad Asset Management reported no remaining Organogenesis Holdings position as of Q2 2020 after selling out during the quarter.
Myriad Asset Management sold 19,076 Organogenesis Holdings shares in Q2 2020, an estimated $61K.
Myriad Asset Management first reported a position in Organogenesis Holdings in Q3 2017 and held it in 7 quarters.
Myriad Asset Management's Organogenesis Holdings position peaked at $5.05M in Q3 2017.
50 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2020.

Based on Myriad Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.